324 related articles for article (PubMed ID: 25103264)
41. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
[TBL] [Abstract][Full Text] [Related]
42. The effect of preservatives and antiglaucoma treatments on the ocular surface of mice with dry eye.
Barabino S; Antonelli S; Cimbolini N; Mauro V; Bouzin M
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6499-504. PubMed ID: 25205861
[TBL] [Abstract][Full Text] [Related]
43. A new nonhuman primate model of severe dry eye.
Qin Y; Tan X; Zhang Y; Jie Y; Labbe A; Pan Z
Cornea; 2014 May; 33(5):510-7. PubMed ID: 24576920
[TBL] [Abstract][Full Text] [Related]
44. Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice.
Chen Y; Zhang X; Yang L; Li M; Li B; Wang W; Sheng M
Mol Med Rep; 2014 May; 9(5):2015-23. PubMed ID: 24626526
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of osmoprotectants on prevention and treatment of murine dry eye.
Chen W; Zhang X; Li J; Wang Y; Chen Q; Hou C; Garrett Q
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6287-97. PubMed ID: 23970467
[TBL] [Abstract][Full Text] [Related]
46. Influence of benzalkonium chloride on langerhans cells in corneal epithelium and development of dry eye in healthy volunteers.
Zhivov A; Kraak R; Bergter H; Kundt G; Beck R; Guthoff RF
Curr Eye Res; 2010 Aug; 35(8):762-9. PubMed ID: 20673054
[TBL] [Abstract][Full Text] [Related]
47. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model.
Seo MJ; Kim JM; Lee MJ; Sohn YS; Kang KK; Yoo M
Curr Eye Res; 2010 Feb; 35(2):165-75. PubMed ID: 20136427
[TBL] [Abstract][Full Text] [Related]
48. Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
Zhang X; Lin X; Liu Z; Wu Y; Yang Y; Ouyang W; Li W; Liu Z
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6056-6064. PubMed ID: 29204644
[TBL] [Abstract][Full Text] [Related]
49. [The protection of hydrogen-rich saline on a rat dry eye model induced by scopolamine hydrobromide].
Chu YY; Hua N; Ru YS; Zhao SZ
Zhonghua Yan Ke Za Zhi; 2017 May; 53(5):363-372. PubMed ID: 28494565
[No Abstract] [Full Text] [Related]
50. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
51. Diclofenac protects cultured human corneal epithelial cells against hyperosmolarity and ameliorates corneal surface damage in a rat model of dry eye.
Sawazaki R; Ishihara T; Usui S; Hayashi E; Tahara K; Hoshino T; Higuchi A; Nakamura S; Tsubota K; Mizushima T
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2547-56. PubMed ID: 24677100
[TBL] [Abstract][Full Text] [Related]
52. Protective effect of uridine on cornea in a rabbit dry eye model.
Oh JY; In YS; Kim MK; Ko JH; Lee HJ; Shin KC; Lee SM; Wee WR; Lee JH; Park M
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1102-9. PubMed ID: 17325152
[TBL] [Abstract][Full Text] [Related]
53. Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease.
Kim YH; Jung JC; Jung SY; Yu S; Lee KW; Park YJ
Cornea; 2016 Feb; 35(2):234-42. PubMed ID: 26619385
[TBL] [Abstract][Full Text] [Related]
54. Conjunctival and corneal pneumatic sensitivity is associated with signs and symptoms of ocular dryness.
Situ P; Simpson TL; Fonn D; Jones LW
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2971-6. PubMed ID: 18390645
[TBL] [Abstract][Full Text] [Related]
55. A murine model of dry eye induced by topical administration of erlotinib eye drops.
Yang QC; Bao J; Li C; Tan G; Wu AH; Ye L; Ye LH; Zhou Q; Shao Y
Int J Mol Med; 2018 Mar; 41(3):1427-1436. PubMed ID: 29286080
[TBL] [Abstract][Full Text] [Related]
56. Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits.
El-Shazly AH; El-Gohary AA; El-Shazly LH; El-Hossary GG
Acta Pharm; 2008 Jun; 58(2):163-73. PubMed ID: 18515226
[TBL] [Abstract][Full Text] [Related]
57. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
[TBL] [Abstract][Full Text] [Related]
58. α-MSH ameliorates corneal surface dysfunction in scopolamine-induced dry eye rats and human corneal epithelial cells via enhancing EGFR expression.
Chu C; Huang Y; Ru Y; Lu X; Zeng X; Liu K; Gan L; Zhang Y; Zhao S
Exp Eye Res; 2021 Sep; 210():108685. PubMed ID: 34252414
[TBL] [Abstract][Full Text] [Related]
59. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.
Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC
Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509
[TBL] [Abstract][Full Text] [Related]
60. Topical apolipoprotein A-1 may have a beneficial effect on the corneal epithelium in a mouse model of dry eye: a pilot study.
Nyunt AK; Ishida Y; Yu Y; Shimada S
Eye Contact Lens; 2008 Sep; 34(5):287-92. PubMed ID: 18779669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]